Reply to 'The case for evidence-based medicine for the association between hyperuricaemia and CKD'
Nat Rev Nephrol
.
2020 Jul;16(7):422-423.
doi: 10.1038/s41581-020-0289-2.
Authors
Yuka Sato
1
,
Daniel I Feig
2
,
Austin G Stack
3
4
,
Duk-Hee Kang
5
,
Miguel A Lanaspa
1
,
A Ahsan Ejaz
6
,
L Gabriela Sánchez-Lozada
7
,
Masanari Kuwabara
8
,
Claudio Borghi
9
,
Richard J Johnson
10
11
Affiliations
1
Division of Renal Diseases and Hypertension, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
2
Division of Pediatric Nephrology, University of Alabama, Birmingham, AL, USA.
3
Division of Nephrology, Department of Medicine, University Hospital Limerick, Limerick, Ireland.
4
Graduate Entry Medical School, University of Limerick, Limerick, Ireland.
5
Division of Nephrology Department of Internal Medicine, Ewha Womans University College of Medicine Ewha Medical Research Center, Seoul, Korea.
6
Division of Nephrology, Hypertension and Renal Transplantation, University of Florida, Gainesville, FL, USA.
7
Dept. Cardio-Renal Physiopathology, INC Ignacio Chavez, Mexico City, Mexico.
8
Department of Cardiology and Intensive Care Unit, Toranomon Hospital, Tokyo, Japan.
9
Department of Medicine, University of Bologna, Bologna, Italy.
10
Division of Renal Diseases and Hypertension, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. richard.johnson@cuanschutz.edu.
11
Rocky Mountain Regional VA Medical Center, Aurora, CO, USA. richard.johnson@cuanschutz.edu.
PMID:
32313213
DOI:
10.1038/s41581-020-0289-2
No abstract available
Publication types
Letter
Comment
MeSH terms
Evidence-Based Medicine
Humans
Hyperuricemia*
Renal Insufficiency, Chronic*
Uric Acid
Substances
Uric Acid